Vision training system

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Dacks Rodriguez patent solves the following problem:

It is important for baseball hitters in recognition not only of different kinds of pitches pitched in a pitcher but also to discern the pitched ball in the strike zone or zone to be successful.

Our analysis of this patent is as follows:

Dacks Rodriguez’s patent US 9457253 B1 deals with Vision training system.
Devices, systems, and methods for training baseball and softball beat, in their eyes the ball up (fast ball, curve ball, slider and changeup) and place (strike or non-strike zone) pitched the ball to adding sufficient accuracy. A motion sensor will be triggered in the first legs in a jar. The motion sensor can face up to them to throw a ball up from the jar. When the motion sensor that causes a signal to be sent to a black out lens that blocks the vision of a hitter trained in identifying species and areas in pitched ball. The training includes the lens transparent to opaque at chosen distance between the hitter and pitcher.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods and products to provide oral nutritional care to subjects with dementia

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The D&E; Gillespie Enterpries LLC patent solves the following problem:

Dementia is a group of disorders characterized by the loss of integrated central nervous system functions, resulting in a diminished ability to understand concepts or instructions, store and retrieve information to memory, and in behavior and personality changes.

Our analysis of this patent is as follows:

D&E; Gillespie Enterpries LLC’s patent US 9456628 B2 deals with Methods and products to provide oral nutritional care to subjects with dementia.
The present invention provides food products, nutritional programs, and procedures for meeting the nutritional needs of those with dementia and related mental disorder. In one embodiment, the invention provides a food product comprising a reversibly sealed vessel and a broth, the broth in the container and consists of a total number 200-2000 MLS, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, 2 % to about 40% medium chain triglyceride, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 strong food particles that have a mass greater than 20 cm3. The food product, when administered to the affected subjects, positive effect (i) nutritional status; (Ii) the quality of life; (Iii) disease course; (B) the need for help from a care giver; (Vi) subject carrying out a nutritional plan to use in food products, and (viii) ease of monitoring compliance with caretaker for verification.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Combination therapy using c-Met inhibitor and c-Myc inhibitor

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Samsung Electronics Co., Ltd. patent solves the following problem:

If a method of preventing and / or treating a cancer, the method including the co-administration of a c-Met inhibitor and a c-Myc inhibitor to a subject in need thereof .

Our analysis of this patent is as follows:

Samsung Electronics Co., Ltd.’s patent US 9457043 B2 deals with Combination therapy using c-Met inhibitor and c-Myc inhibitor.
A method of preventing and / or treating a cancer including co-administering a c-Met inhibitor and a c-Myc inhibitor to a subject in need thereof, a pharmaceutical composition comprising a c-Met inhibitor and a c-Myc inhibitor, and a kit comprising a pharmaceutically effective amount of one-Met inhibitor as an active ingredient, and a second pharmaceutical composition comprising a pharmaceutically effective amount of one-Myc inhibitor as an active ingredient, packaged together.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Genmab A/S patent solves the following problem:

The EGF receptor (EGFR) is a 170 kDa type 1 transmembrane molecules. The expression found upregulated in many human tumors including carcinoma of the head and neck, breast, colon, prostate, lung, and ovaries. The kind of over-expression correlated with poor clinical prognosis (Baselga, et al (1994) Pharmac therapeut 64: ….. 127-154; Modjtahedi, et al (1994) Int J. Oncology 4: 277-296). Furthermore, his expression always accompanied by the production of EGFR ligands, TGF- and EGF among others, by EGFR-expressing tumor cells suggests that an autocrine loop participates in growth this cells (Baselga, et al. (1994) Pharmac therapeut 64: …. 127-154; Modjtahedi, et al (1994) Int J. Oncology 4: 277-296) .. Ali interaction between such EGFR ligands and EGFR therefore can inhibit tumor growth and survival (Baselga, et al (1994) Pharmac therapeut 64: 127-154).

Our analysis of this patent is as follows:

Genmab A/S’s patent US 9458236 B2 deals with Human monoclonal antibodies to epidermal growth factor receptor (EGFR).
Isolated human monoclonal antibody that specifically binds to human EGFR, and related antibody-based compositions and molecules, are disclosed. The human antibody can be produced in a transfectoma or a non-human transgenic animals, for example, a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing VDJ recombination and isotype switch. also discloses pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas that produce human antibodies, and therapeutic and diagnostic methods using human antibody.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The The Brigham And Women’s Hospital, Inc., , Beth Israel Deaconess Medical Center, Inc. patent solves the following problem:

Staphylococci programs-positive bacteria normally inhabit and colonize the skin and mucus membranes of humans. If the skin or mucus membranes can be damaged during surgery or other trauma, the staphylococci to gain access to internal tissues causing infection to develop. When the staphylococci proliferate locally or enter the lymphatic or blood system, serious infectious complications associated with staphylococcal bacteremia may result. Complications associated with Staphylococcal bacteremia include septic shock, endocarditis, arthritis, osteomyelitis, pneumonia, and abscesses in various organs.

Our analysis of this patent is as follows:

The Brigham And Women’s Hospital, Inc., , Beth Israel Deaconess Medical Center, Inc.’s patent US 9458227 B2 deals with Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof.
The present invention relates to peptide, particularly human monoclonal antibody, which are particularly poly-N-acetyl glucosamine (pnag), as Staphylococcal pnag, acetylated, partially acetylated and / or fully deacetylated form. The invention further provides methods of using these peptides in the diagnosis, Branch Tomato and therapy of bacterial expression pnag such as but not limited to staphylococci and E. coli. The other antibody formulation development opsonophagocytic murder and in vivo protection against bacteria expressing pnag such as but not limited to staphylococci and E. coli. Composition of these peptides, including pharmaceutical compositions, which also, as functionally equivalent variants of the peptide.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Load sensing system for wheelchair lift arrangement

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Ricon Corp. patent solves the following problem:

The present invention relates in general to access the system and wheelchair lift arrangement, for example wheelchair lift arrangement for use in connection with a car, and, in particular, a load sensing system and arrangement for use in connection with such access systems and wheelchair lift arrangement.

Our analysis of this patent is as follows:

Ricon Corp.’s patent US 9456940 B2 deals with Load sensing system for wheelchair lift arrangement.
A load sensing system for a wheelchair lift arrangement includes an elongated member is rotatable about a longitudinal axis between an unloaded position and a loaded position; a biasing member biases the elongated member into the unloading position; at least one contact member connected to the elongated member and configured to contact a bridge plate; and a switch assembly operatively connected to the elongated member, the switch assembly configured to activate operation to prevent the wheelchair lift arrangement when the elongated member is the chief position. A method of controlling movement of a lift platform with a wheelchair lift arrangement also provided.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

System and method for performing surgical procedures with a reusable instrument module

File for Quick & Easy Patent Protection with PowerPatent.

The Covidien Lp patent solves the following problem:

The present disclosure relates generally to the field of reposable or reusable opera. In particular, the disclosure relates to instruments with separable and replaceable components to provide clean, sterile or renovated over time.

Our analysis of this patent is as follows:

Covidien Lp’s patent US 9456873 B2 deals with System and method for performing surgical procedures with a reusable instrument module.
A surgical instrument includes an outer housing shell defining a cavity. The outer housing shell defines an upper outer housing half and a lower outer housing of the half. The upper outer housing half defines a longitudinal axis. An instrument module is selectively insertable into the hole in the outer housing shell. The instrument module includes an inner housing shell, at least one motor disposed in the housing shell, a control board in electrical communication with at least one motor, and an energy source in electrical communication with at least one motor and the control board. The instrument module is inserted into the hole in the outer housing shell in such a way that the operative axis at least one motor that substantially parallel to the longitudinal axis on the outer half of the housing.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method for individually servicing a plurality of zones of a subterranean formation

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Halliburton Energy Services, Inc. patent solves the following problem:

Underground formation containing hydrocarbons sometimes not consistent in their composition along the length of the wellbores that extend into the formation. It is sometimes desirable to treat and / or other building management and / or the wellbore in different ways to respond to various formation composition. Some wellbore servicing systems and procedures to allow such treatment, referred to by some as the zonal isolation treatment. However, some systems wellbore servicing and procedures, while many tools for use in the treatment zones may activate an obturator, the activation of a tool obturator causes activation of additional tools to be more difficult. For example, a ball may be used to activate a number of stimulation devices, thereby allowing fluid communication between a flow bore equipped with a space outside the device. However, the fluid communication fulfilled to activate a tool to increase the working pressure required in order to activate additional tools. Therefore, there is a need for improved systems and methods for treating many zones in a wellbore.

Our analysis of this patent is as follows:

Halliburton Energy Services, Inc.’s patent US 9458697 B2 deals with Method for individually servicing a plurality of zones of a subterranean formation.
A method of service in a subterranean formation comprising providing a first sleeve system containing a first one or more ports and transitionable from a first mode to a second mode and the second mode is a third mode, and a second sleeve system containing a second one or more ports and transitionable from a first mode to a second mode and the second mode in a third way, which, in the first step and the second way, fluid communication with one or more ports in the first or second arm system forbidden, and where, the third way, fluid can be conveyed through one or more ports in the first or second arm system, move the first and second arm system in the second mode, and allow the arm system to transition from the the second way to the third way.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Livestock control and monitoring system and method

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Kim McLaughlin patent solves the following problem:

It is known to use the land coral when managing livestock or other animals to keep the animal in a desired place. These on-field fence to take a variety of forms, such as fence posts, barbed wire fences, and electrical fences fortified with a low level electrical pulse. Moreover, the animal control system known implementation buried wires, commonly known as the invisible fence. These invisible fence includes a transmitter that generates a sign signal that falls on a wire loop antenna buried a few inches under the ground and that describes a place animals are in or from which the animals restricted. However, both of these systems include the costly installation of a physical structure that requires maintenance, exposed to the elements, it is difficult or impossible to move, and expensive to install.

Our analysis of this patent is as follows:

Kim McLaughlin’s patent US 9456584 B2 deals with Livestock control and monitoring system and method.
A system and method for controlling and monitoring an animal which includes receiving a plurality of GPS Coordinates defining a boundary of a predetermined area of ​​the animal is imprisoned, receiving, with a transceiver, at least a signal showing a position in the animal over which the receiver mounted in a house, monitor, by at least one sensor, a physiological state of animals, determining, by a processor in electrical communication with the receiver, if the animal is within a predetermined distance in a predetermined place, defined by a plurality of GPS coordinates, based on at least a signal place, and to administer a stimulus to the animal by at least one stimulus device attached to the housing and in electrical communication with the processor upon a determination that the animals are within a predetermined distance on a predetermined place.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The University Of Manitoba patent solves the following problem:

Our analysis of this patent is as follows:

University Of Manitoba’s patent US 9457073 B2 deals with Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity.
The present invention relates to copying worthy Arteriviruses with a decreased dub / deISGylating activity due to a mutation in PLP2 domain of non-structural proteins nsp2, to their use as a medicine, use as a vaccine and Branch Tomato, the vaccine contains such Arteriviruses and Arteriviral PLP2-ubiquitin complexes.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.